Muinah A. Fowora

Yaba, LA, Nigeria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

EXPRESSION AND IMMUNOASSAY ASSESSMENT OF IMMUNOMODULATORY PanDR AND SARS-CoV-2 RECEPTOR-BINDING DOMAIN ANTIGEN IN BACTERIA HOST CELL.

EXPRESSION AND IMMUNOASSAY ASSESSMENT OF IMMUNOMODULATORY PanDR AND SARS-CoV-2 RECEPTOR-BINDING DOMAIN ANTIGEN IN BACTERIA HOST CELL.

Journal: Protein expression and purification

Published: March 27, 2026

Recovery of Escherichia coli and Salmonella enterica from long frozen rectal swabs using enrichment methods in a low-resource setting.

Recovery of Escherichia coli and Salmonella enterica from long frozen rectal swabs using enrichment methods in a low-resource setting.

Journal: Journal of microbiological methods

Published: November 01, 2025

Co-infections of Schistosoma mansoni and Helicobacter pylori in school-aged populations and implication for management and control practices in Niger State, Nigeria.

Co-infections of Schistosoma mansoni and Helicobacter pylori in school-aged populations and implication for management and control practices in Niger State, Nigeria.

Journal: PloS one

Published: July 28, 2025

Evidence of anthrax virulence genes in Bacillus aerius and human exposure in largest abattoir in Lagos, Nigeria.

Evidence of anthrax virulence genes in Bacillus aerius and human exposure in largest abattoir in Lagos, Nigeria.

Journal: One health outlook

Published: May 01, 2025

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.

Journal: Trials

Published: November 16, 2024

Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19.

Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19.

Journal: Molecular biology reports

Published: February 05, 2024

Effect of nasal carriage of Bacillus species on COVID-19 severity: a cross-sectional study.

Effect of nasal carriage of Bacillus species on COVID-19 severity: a cross-sectional study.

Journal: Microbiology spectrum

Published: January 09, 2024

Whole genome sequencing and phylogenetic analysis of SARS-CoV-2 strains isolated during the COVID-19 pandemic in Nigeria.

Whole genome sequencing and phylogenetic analysis of SARS-CoV-2 strains isolated during the COVID-19 pandemic in Nigeria.

Journal: IJID regions

Published: December 08, 2023

A survey of chloroquine use for prevention and treatment of COVID-19 in Nigeria.

A survey of chloroquine use for prevention and treatment of COVID-19 in Nigeria.

Journal: African health sciences

Published: August 07, 2023

Corrigendum: Fetoplacental transmission and placental response to SARS-CoV-2: evidence from the literature.

Corrigendum: Fetoplacental transmission and placental response to SARS-CoV-2: evidence from the literature.

Journal: Frontiers in medicine

Published: August 03, 2023

Multidrug-Resistant Kocuria rosea and Methicillin-Resistant Staphylococcus aureus Co-Infection in a Nigerian Patient with COVID-19: A Case Report.

Multidrug-Resistant Kocuria rosea and Methicillin-Resistant Staphylococcus aureus Co-Infection in a Nigerian Patient with COVID-19: A Case Report.

Journal: The American journal of case reports

Published: March 31, 2023

Fetoplacental transmission and placental response to SARS-CoV-2: Evidence from the literature.

Fetoplacental transmission and placental response to SARS-CoV-2: Evidence from the literature.

Journal: Frontiers in medicine

Published: June 06, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026